David Wohl, MD

David Wohl, MD

Infectious Disease Pinehurst, NC

Associate Professor, Medicine, University of North Carolina at Chapel Hill School of Medicine


Office Address

  • 155 Memorial Dr
    Pinehurst, NC 28374
    Phone: (910) 715-1000
    Fax: (910) 715-1926

Are you Dr. Wohl?

Claim your profile and join over 50% of U.S. physicians already on Doximity.

Claim this pageNo, this isn't me

David Wohl, MD

Infectious Disease Pinehurst, NC

Associate Professor, Medicine, University of North Carolina at Chapel Hill School of Medicine

28 Colleague InvitesIs this you? Register Now to see 28 messages.

Summary

  • Dr. David Wohl, MD is a board certified infectious disease specialist in Pinehurst, North Carolina. He is currently licensed to practice medicine in North Carolina. He is affiliated with University of North Carolina Hospitals and is an Associate Professor at University of North Carolina at Chapel Hill School of Medicine

Clinical Specialties & Interests

  • Infectious Disease: General Infectious Disease

Education & Medical Training

  • Duke University HospitalDuke University Hospital
  • Rutgers Robert Wood Johnson Medical SchoolRutgers Robert Wood Johnson Medical School
  • University of North Carolina HospitalsUniversity of North Carolina Hospitals

Certifications & Licensure

  • NC State Medical LicenseNC State Medical License1994 - 2015
  • American Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineInfectious Disease

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • RCT Of An Augmented Test, Treat, Link, &Retain Model For NC And Texas PrisonersNational Institute On Drug Abuse
    2010 - 2011
  • Clinical Trial: Two Doses Of Gw433908/Ritonavir Given With Abacavir/Lamivudine CNational Center For Research Resources
    2008 - 2008
  • Clinical Trial: Phase I/II Uridine Supplementation In HIV Lipoatrophy (Actg A522National Center For Research Resources
    2008 - 2008
  • Clinical Trial: A5235 - Minocycline In The Treatment Of Hiv-Associated CognitiveNational Center For Research Resources
    2008 - 2008
  • Clinical Trial: Enfurvitide (T-20) Intensification For Low Level Viremia (The LoNational Center For Research Resources
    2008 - 2008
  • Clinical Trial: MRK AD5 HIV-1 GAG Vaccine In HIV-1 Subjects WHO Interupt TherapyNational Center For Research Resources
    2008 - 2008
  • Enfurvitide (T-20) Intensification For Low Level Viremia (The Lola Study)National Center For Research Resources
    2007 - 2007
  • Incarceration And Hiv-Infected InmatesNational Institute Of Mental Health
    2007 - 2010
  • Phase 3 Comparison Of Lopinavir/Ritonavir Efavirenz Stavudine Lamivudine For IniNational Center For Research Resources
    2007 - 2007
  • Phase I/II Uridine Supplementation In HIV Lipoatrophy (Actg A5229)National Center For Research Resources
    2007 - 2007
  • Two Doses Of Gw433908/Ritonavir Given With Abacavir/Lamivudine ComboNational Center For Research Resources
    2006 - 2007
  • Long-Term Antiviral Management Of HCV And HIV-1 Coinfected Subjects (Slam-C)National Center For Research Resources
    2006 - 2008
  • Ezetimibe Therapy For Dyslipidemia In Patients Receiving HIV TherapyNational Center For Research Resources
    2006 - 2007
  • MRK AD5 HIV-1 GAG Vaccine In HIV-1 Subjects WHO Interupt TherapyNational Center For Research Resources
    2006 - 2007
  • Fat Redistribution And Metabolic Change In HIV InfectionNational Center For Research Resources
    2005 - 2008
  • Nutriceuticals D-Glucarate, Silymarin And Piperine On PharmacokineticsNational Center For Research Resources
    2005 - 2007
  • Combination Therapy With Fish Oil Supplement And FenofibrateNational Center For Research Resources
    2005 - 2006
  • Fish Oil Supplementation PLUS Diet And Excercise VS Diet And Exercise Alone-HivNational Center For Research Resources
    2005 - 2005
  • Antiretroviral Switch At Lower VS Higher HIV-1 RNA Levels With RelapseNational Center For Research Resources
    2005 - 2006
  • Potent Combo Antiretroviral Regimen In AA Men And WomenNational Center For Research Resources
    2005 - 2005
  • ACTG A5142National Center For Research Resources
    2004 - 2006
  • Metformin And Rosiglitazone Alone Or In Combination In Hiv-Infected SubjectsNational Center For Research Resources
    2004 - 2005
  • Immune Response To Pneumococcal Vaccine In Patients With HIVNational Center For Research Resources
    2004 - 2005
  • Fish Oil Supplementation PLUS Diet And Excercise Vs. Diet And Exercise Alone-HivNational Center For Research Resources
    2004 - 2004
  • Valganciclovir Pre-Emptive Therapy For CMV Viremia (Actg A5030)National Center For Research Resources
    2004 - 2006
  • Combinations Of Potent Antiretroviral Therapy, Hiv-Specific ImmunizationsNational Center For Research Resources
    2004 - 2004
  • Antiretroviral Switch At Lower Vs. Higher HIV-1 RNA Levels With RelapseNational Center For Research Resources
    2004 - 2004
  • Phase II Once-Weekly Alendronate In Hiv-Infected Subjects With Decreased Bone DNational Center For Research Resources
    2004 - 2007
  • Potent Combination Of Antiretroviral Regimen In African-American Men And WomenNational Center For Research Resources
    2004 - 2007
  • HIV+ Prison Releases To Access To HIV Care And ServicesNational Institute On Drug Abuse
    2003 - 2007
  • Trial Of Salvage Antiretroviral Therapies For HIV PTSNational Center For Research Resources
    2000 - 2000
  • Ddl/D4t/Hu VS Ddl/D4t/Efv VS Protease Inhibitor In HIV PTSNational Center For Research Resources
    2000 - 2000
  • HIV &Cmv &Development Of CMV End-Organ DiseaseNational Center For Research Resources
    2000 - 2000
  • Thalidomide For Recurrent Aphthous Stomatitis In HIVNational Center For Research Resources
    2000 - 2000
  • The Longitudinal Study Of Ocular Complications Of AIDSNational Center For Research Resources
    2000 - 2000
  • Abt378/Ritonavir W/ Reverse Transcriptase Inhibitors In HIVNational Center For Research Resources
    2000 - 2000
  • A Longitudinal Study Of Quantitative CMV In Pys W/ AIDSNational Center For Research Resources
    2000 - 2000
  • Ganciclovir Cidofovir CMV Retinitis TrialNational Center For Research Resources
    1999 - 2002
  • ACTG 379 Discontinuing Maintenance Therapy For CMV RetinitisNational Center For Research Resources
    1999 - 2002
  • Thalidomide For Treatment Of Recurrent Aphthous Ulcers In HIVNational Center For Research Resources
    1999 - 2002
  • NCI AIDS Related Cancer Cohort Study (ACCS)National Center For Research Resources
    1999 - 2002
  • HIV And CMV Viral Burden And Development Of CMV End-Organ DiseaseNational Center For Research Resources
    1998 - 2002
  • Investigational New Drug Application For HIVNational Center For Research Resources
    1998 - 1999
  • A Longitudinal Study Of The Predictive Value Of Quantitative CMVNational Center For Research Resources
    1997 - 2002

Hospital Affiliations

Insurance Accepted

  • BCBS Blue Card PPO
  • BCBS North Carolina BlueOptions PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Alternate Names

  • Dr. David Wohl, Dr. David Wohl, MD, Dr. D Wohl, Dr. David A Wohl

Physicians, view Dr. Wohl's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV

© 2015 Doximity, Inc.HelpBlogCompanyContactPrivacyDirectory